The aim of this study was to investigate the efficacy of a direct acoustic cochlear implant (DACI) for speech understanding in noise in patients suffering from severe to profound mixed hearing loss (MHL) due to various etiologies compared to the preoperative best-aided condition. The study was performed at five tertiary referral centers in Europe (Belgium, Germany, Poland and Spain). Nineteen adult subjects with severe to profound MHL due to (advanced) otosclerosis, ear canal fibrosis, chronic otitis media, tympanosclerosis or previous cholesteatoma were implanted with a DACI (Codacs™ Investigational Device) combined with a conventional stapes prosthesis. Unaided and aided speech reception scores in quiet and in noise, preoperative and postoperative air and bone conduction thresholds and aided and unaided sound field thresholds were measured prospectively during the study. Subjective benefit analysis was determined through the Abbreviated Profile of Hearing Aid Benefit questionnaire. Quality of life was measured by the Health Utilities Index. All subjects were fitted preoperatively with hearing aids and/or a bone conduction implant on a headband before DACI implantation. This allows direct comparison between different hearing rehabilitation solutions. The mean speech reception threshold in noise improved significantly by 7.9 dB signal-to-noise ratio (SNR) after activation of the DACI compared to the preoperative best-aided condition. For all 19 subjects, a mean postoperative aided speech reception threshold of 2.6 dB SNR (standard deviation: 8.3 dB) was measured. On average, no significant shift in the bone conduction thresholds was noted 4-5 months after implantation. A mean sound field threshold improvement of 46 and 16 dB was measured compared to the preoperative unaided and best-aided condition, respectively. Speech perception tests in quiet showed a mean improvement of the word recognition scores by 65 and 48% at 65 dB SPL compared to the preoperative unaided and best-aided condition, respectively. In summary, DACI provides an effective improvement of the speech perception in noise compared to the best-aided condition in subjects suffering from severe to profound MHL.

1.
Baumgartner W-D, Böheim K, Hagen R, Müller J, Lenarz T, Reiss S, et al: The vibrant soundbridge for conductive and mixed hearing losses: European multicenter study results. Adv Otorhinolaryngol 2010;69:38-50.
2.
Beleites T, Neudert M, Beutner D, Hüttenbrink K-B, Zahnert T: Experience with vibroplasty couplers at the stapes head and footplate. Otol Neurotol 2011;32:1468-1472.
3.
Beltrame AM, Martini A, Prosser S, Giarbini N, Streitberger C: Coupling the Vibrant Soundbridge to cochlea round window: auditory results in patients with mixed hearing loss. Otol Neurotol 2009;30:194-201.
4.
Bernardeschi D, Hoffman C, Benchaa T, Labassi S, Beliaeff M, Sterkers O, et al: Functional results of Vibrant Soundbridge middle ear implants in conductive and mixed hearing losses. Audiol Neurootol 2011;16:381-387.
5.
Bernhard H, Stieger C, Perriard Y: New implantable hearing device based on a micro-actuator that is directly coupled to the inner ear fluid. Conf Proc IEEE Eng Med Biol Soc 2006;1:3162-3165.
6.
Böheim K, Mlynski R, Lenarz T, Schlögel M, Hagen R: Round window vibroplasty: long-term results. Acta Otolaryngol 2012;132:1042-1048.
7.
Bosman AJ, Snik AFM, Mylanus EAM, Cremers CWRJ: Fitting range of the BAHA Cordelle. Int J Audiol 2006;45:429-437.
8.
Büchner A, Schüssler M, Battmer RD, Stöver T, Lesinski-Schiedat A, Lenarz T: Impact of low-frequency hearing. Audiol Neurootol 2009;14(suppl 1):8-13.
9.
Colletti L, Mandalà M, Colletti V: Long-term outcome of round window Vibrant SoundBridge implantation in extensive ossicular chain defects. Otolaryngol Head Neck Surg 2013;149:134-141.
10.
Cox RM, Alexander GC: The Abbreviated Profile of Hearing Aid Benefit. Ear Hear 1995;16:176-186.
11.
Devèze A, Koka K, Tringali S, Jenkins HA, Tollin DJ: Active middle ear implant application in case of stapes fixation: a temporal bone study. Otol Neurotol 2010;31:1027-1034.
12.
Drummond M: Introducing economic and quality of life measurements into clinical studies. Ann Med 2001;33:344-349.
13.
Dumon T, Gratacap B, Firmin F, Vincent R, Pialoux R, Casse B, et al: Vibrant Soundbridge middle ear implant in mixed hearing loss: indications, techniques, results. Rev Laryngol Otol Rhinol (Bord) 2009;130:75-81.
14.
Fraysse B, Macías AR, Sterkers O, Burdo S, Ramsden R, Deguine O, et al: Residual hearing conservation and electroacoustic stimulation with the nucleus 24 contour advance cochlear implant. Otol Neurotol 2006;27:624-633.
15.
Häusler R, Stieger C, Bernhard H, Kompis M: A novel implantable hearing system with direct acoustic cochlear stimulation. Audiol Neurootol 2008;13:247-256.
16.
Heywood RL, Patel PM, Jonathan DA: Comparison of hearing thresholds obtained with Baha preoperative assessment tools and those obtained with the osseointegrated implant. Ear Nose Throat J 2011;90:E21-E27.
17.
Hüttenbrink K-B, Beutner D, Bornitz M, Luers JC, Zahnert T: Clip vibroplasty: experimental evaluation and first clinical results. Otol Neurotol 2011;32:650-653.
18.
Lachance S, Bussières R, Côté M: Stapes surgery in profound hearing loss due to otosclerosis. Otol Neurotol 2012;33:721-723.
19.
Lenarz T, Zwartenkot JW, Stieger C, Schwab B, Mylanus EAM, Caversaccio M, et al: Multicenter study with a direct acoustic cochlear implant. Otol Neurotol 2013;34:1215-1225.
20.
Luers JC, Hüttenbrink K-B, Zahnert T, Bornitz M, Beutner D: Vibroplasty for mixed and conductive hearing loss. Otol Neurotol 2013;34:1005-1012.
21.
Martin C, Deveze A, Richard C, Lefebvre PP, Decat M, Ibañez LG, et al: European results with totally implantable Carina placed on the round window: 2-year follow-up. Otol Neurotol 2009;30:1196-1203.
22.
Merkus P, van Loon MC, Smit CF, Smits C, de Cock AFC, Hensen EF: Decision making in advanced otosclerosis: an evidence-based strategy. Laryngoscope 2011;121:1935-1941.
23.
Rajan GP, Lampacher P, Ambett R, Dittrich G, Kuthubutheen J, Wood B, et al: Impact of floating mass transducer coupling and positioning in round window vibroplasty. Otol Neurotol 2011;32:271-277.
24.
Ramsden R, Rotteveel L, Proops D, Saeed S, van Olphen A, Mylanus E: Cochlear implantation in otosclerotic deafness. Adv Otorhinolaryngol 2007;65:328-334.
25.
Rotteveel LJC, Proops DW, Ramsden RT, Saeed SR, van Olphen AF, Mylanus EA: Cochlear implantation in 53 patients with otosclerosis: demographics, computed tomographic scanning, surgery, and complications. Otol Neurotol 2004;25:943-952.
26.
Schwab B, Salcher RB, Maier H, Kontorinis G: Oval window membrane vibroplasty for direct acoustic cochlear stimulation: treating severe mixed hearing loss in challenging middle ears. Otol Neurotol 2012;33:804-809.
27.
Skarzynski H, Lorens A, Matusiak M, Porowski M, Skarzynski PH, James CJ: Partial deafness treatment with the nucleus straight research array cochlear implant. Audiol Neurootol 2012;17:82-91.
28.
Snapp HA, Fabry DA, Telischi FF, Arheart KL, Angeli SI: A clinical protocol for predicting outcomes with an implantable prosthetic device (Baha) in patients with single-sided deafness. J Am Acad Audiol 2010;21:654-662.
29.
Snik AFM, Mylanus EAM, Proops DW, Wolfaardt JF, Hodgetts WE, Somers T, et al: Consensus statements on the BAHA system: where do we stand at present? Ann Otol Rhinol Laryngol Suppl 2005;195:2-12.
30.
Toung JS, Zwolan T, Spooner TR, Telian SA: Late failure of cochlear implantation resulting from advanced cochlear otosclerosis: surgical and programming challenges. Otol Neurotol 2004;25:723-726.
31.
Verhaegen VJO, Mulder JJS, Cremers CWRJ, Snik AFM: Application of active middle ear implants in patients with severe mixed hearing loss. Otol Neurotol 2012;33:297-301.
32.
Verhaegen VJO, Mulder JJS, Mylanus EAM, Cremers CWRJ, Snik AFM: Profound mixed hearing loss: bone-anchored hearing aid system or cochlear implant? Ann Otol Rhinol Laryngol 2009;118:693-697.
33.
Verhaert N, Desloovere C, Wouters J: Acoustic hearing implants for mixed hearing loss: a systematic review. Otol Neurotol 2013;34:1201-1209.
34.
Verhaert N, Fuchsmann C, Tringali S, Lina-Granade G, Truy E: Strategies of active middle ear implants for hearing rehabilitation in congenital aural atresia. Otol Neurotol 2011;32:639-645.
35.
Vincent R, Oates J, Sperling NM: Stapedotomy for tympanosclerotic stapes fixation: is it safe and efficient? A review of 68 cases. Otol Neurotol 2002;23:866-872.
36.
van Wieringen A, Wouters J: LIST and LINT: sentences and numbers for quantifying speech understanding in severely impaired listeners for Flanders and the Netherlands. Int J Audiol 2008;47:348-355.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.